PharmaCyte Biotech

PharmaCyte Biotech EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of PharmaCyte Biotech (PMCB) as of Oct 22, 2026 is -6.85 M USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -4.38 M USD — a change of 56.55% (lower).

EBITDA

-6.85 MUSD

YoY

56.55%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of PharmaCyte Biotech is 2026 -6.85 M USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of PharmaCyte Biotech was 2025 -4.38 M USD. It decreases by 56.55% lower compared to the previous year.

The PharmaCyte Biotech EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2019
-4.10 M USD
Jan 1, 2020
-3.83 M USD
Jan 1, 2021
-3.62 M USD
Jan 1, 2022
-4.39 M USD
Jan 1, 2023
-6.46 M USD
Jan 1, 2024
-8.52 M USD
Jan 1, 2025
-4.38 M USD
Jan 1, 2026
-6.85 M USD
The PharmaCyte Biotech EBITDA history
YEAREBITDAYoY
-6.85 MUSD+56.55%
-4.38 MUSD-48.62%
-8.52 MUSD+31.98%
-6.46 MUSD+46.98%
-4.39 MUSD+21.23%
-3.62 MUSD-5.32%
-3.83 MUSD-6.69%
-4.10 MUSD-41.26%
-6.98 MUSD+57.16%
-4.44 MUSD-26.86%
-6.07 MUSD-55.65%
-13.70 MUSD-27.84%
-18.98 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

PharmaCyte Biotech Stock analysis

What does PharmaCyte Biotech do? PharmaCyte Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PharmaCyte Biotech stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of PharmaCyte Biotech is -6.85 M USD in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of PharmaCyte Biotech changed from -4.38 M USD to -6.85 M USD, representing a 56.55% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) PharmaCyte Biotech since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s PharmaCyte Biotech historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — PharmaCyte Biotech

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — PharmaCyte Biotech